Announced today by Robert Pryke PFD Capital Partners, LLC, Director and Fund manager for PFD Management Opportunity Fund 3001, LLC, recognition of the ‘Wound Repair Regen. Author Manuscript’ dated 2022 May 09. Food and Drug Administration perspective: Advancing product development for non-healing chronic wounds.”